Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients.

Brown JR, Byrd JC, Ghia P, Sharman JP, Hillmen P, Stephens DM, Sun C, Jurczak W, Pagel JM, Ferrajoli A, Patel P, Tao L, Kuptsova-Clarkson N, Moslehi J, Furman RR

Open source

DOI: 10.3324/haematol.2021.278901
Published: 2022 Jun 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2021.278901,
  title = {Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients.},
  author = {Brown JR and Byrd JC and Ghia P and Sharman JP and Hillmen P and Stephens DM and Sun C and Jurczak W and Pagel JM and Ferrajoli A and Patel P and Tao L and Kuptsova-Clarkson N and Moslehi J and Furman RR},
  year = {2022},
  journal = {Haematologica},
  doi = {10.3324/haematol.2021.278901},
  url = {https://doi.org/10.3324/haematol.2021.278901}
}

RIS

TY  - JOUR
TI  - Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients.
AU  - Brown JR
AU  - Byrd JC
AU  - Ghia P
AU  - Sharman JP
AU  - Hillmen P
AU  - Stephens DM
AU  - Sun C
AU  - Jurczak W
AU  - Pagel JM
AU  - Ferrajoli A
AU  - Patel P
AU  - Tao L
AU  - Kuptsova-Clarkson N
AU  - Moslehi J
AU  - Furman RR
PY  - 2022
JO  - Haematologica
DO  - 10.3324/haematol.2021.278901
UR  - https://doi.org/10.3324/haematol.2021.278901
ER  -

APA

JR, B., JC, B., P, G., JP, S., P, H., DM, S., C, S., W, J., JM, P., A, F., P, P., L, T., N, K., J, M., & RR, F. (2022). Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients.. Haematologica. https://doi.org/10.3324/haematol.2021.278901

Source records

pubmed · retrieved 2026-09-26T20:00:19.917Z